Download PDF
Neuropediatrics 2013; 44(04): 230-232
DOI: 10.1055/s-0033-1333875
Short Communication
Georg Thieme Verlag KG Stuttgart · New York

Cognitive Ability in Children with Chronic Granulomatous Disease: A Comparison of Those Managed Conservatively with Those Who Have Undergone Hematopoietic Stem Cell Transplant

Theresa S. Cole
1   Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
,
Fiona McKendrick
2   Department of Health Psychology, Newcastle and North Tyneside NHS Trust, Newcastle upon Tyne, United Kingdom
,
Andrew J. Cant
1   Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
,
Mark S. Pearce
3   Institute of Health and Society, Newcastle University, Newcastle upon Tyne, United Kingdom
,
Catherine M. Cale
4   Department of Clinical Immunology, Great Ormond Street Hospital, London, United Kingdom
,
David R. Goldblatt
5   Institute of Child Health, University College London, London, United Kingdom
,
Andrew R. Gennery
1   Institute of Cellular Medicine, Newcastle University, Newcastle upon Tyne, United Kingdom
,
Penny Titman
6   Department of Psychosocial Services, Great Ormond Street Hospital, London, United Kingdom
› Author Affiliations
Further Information

Publication History

29 October 2012

19 December 2012

Publication Date:
08 February 2013 (online)

    Permissions and Reprints

Abstract

Chronic granulomatous disease (CGD) is a primary immunodeficiency managed conservatively or with hematopoietic stem cell transplant. Studies have shown people with CGD and those transplanted for primary immunodeficiencies have lower than average cognitive ability. In this study, IQ in children with CGD and those transplanted for it was within the normal range.

Keywords

cognitive ability - chronic granulomatous disease - hematopoietic stem cell transplant
 

  • References

  • 1 Pao M, Wiggs EA, Anastacio MM , et al. Cognitive function in patients with chronic granulomatous disease: a preliminary report. Psychosomatics 2004; 45 (3) 230-234
    CrossrefPubMedGoogle Scholar
  • 2 Schäppi MG, Jaquet V, Belli DC, Krause KH. Hyperinflammation in chronic granulomatous disease and anti-inflammatory role of the phagocyte NADPH oxidase. Semin Immunopathol 2008; 30 (3) 255-271
    CrossrefPubMedGoogle Scholar
  • 3 Kishida KT, Hoeffer CA, Hu D, Pao M, Holland SM, Klann E. Synaptic plasticity deficits and mild memory impairments in mouse models of chronic granulomatous disease. Mol Cell Biol 2006; 26 (15) 5908-5920
    CrossrefPubMedGoogle Scholar
  • 4 Titman P, Pink E, Skucek E , et al. Cognitive and behavioral abnormalities in children after hematopoietic stem cell transplantation for severe congenital immunodeficiencies. Blood 2008; 112 (9) 3907-3913
    CrossrefPubMedGoogle Scholar
  • 5 Rogers MH, Lwin R, Fairbanks L, Gerritsen B, Gaspar HB. Cognitive and behavioral abnormalities in adenosine deaminase deficient severe combined immunodeficiency. J Pediatr 2001; 139 (1) 44-50
    PubMedGoogle Scholar
  • 6 Cole TS, McKendrick F, Titman P , et al. Health related quality of life and emotional health in children with chronic granulomatous disease: a comparison of those managed conservatively with those that have undergone haematopoietic stem cell transplant. J Clin Immunol 2012; 33 (1) 8-13
    PubMedGoogle Scholar
  • 7 Zhu J, Manual WASI. San Antonio, TX: Pearson; 1999
  • 8 Kishida KT, Pao M, Holland SM, Klann E. NADPH oxidase is required for NMDA receptor-dependent activation of ERK in hippocampal area CA1. J Neurochem 2005; 94 (2) 299-306
    CrossrefPubMedGoogle Scholar